ABC | Volume 114, Nº2, Fevereiro 2020

Artigo Original Stefani et al. Dano em DNA e insuficiência cardíaca Arq Bras Cardiol. 2020; 114(2):234-242 1. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, BöhmM, Dickstein K, et al. ESCGuidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaborationwith theHeart. Eur Heart J. 2012;14(8):803–69. 2. Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S, et al. Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol. 2015 Jan 15;178:239–46. 3. ZizolaC,SchulzePC.Metabolicandstructural impairmentofskeletalmuscle in heart failure. Heart Fail Rev. 2013;18(5):623–30. 4. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90. 5. Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J. The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes. J Muscle Res Cell Motil. 2015;36(6):377–93. 6. Kobulnik J, DelgadoD. Experimental biomarkers in heart failure: An update. Expert Rev Cardiovasc Ther. 2012;10(9):1119–32. 7. Kobayashi S, Susa T, Tanaka T, Wada Y, Okuda S, Doi M, et al. Urinary 8-hydroxy-2’-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure. Eur J Heart Fail. 2011;13(1):29–36. 8. Collins AR. The comet assay: A heavenly method! Mutagenesis. 2015;30(1):1–4. 9. Olive PL, Banáth JP. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc. 2006;1(1):23–9. 10. Collins AR. Measuring oxidative damage to DNA and its repair with the comet assay. Biochim Biophys Acta - Gen Subj. 2014;1840(2):794–800. 11. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44(4):503–12. 12. Cicogna AC, Robinson KG, Conrad CH, Singh K, Squire R, Okoshi MP, et al. Direct Effects of Colchicine on Myocardial Function: Studies in Hypertrophied and Failing SpontaneouslyHypertensive Rats. Hypertension. 1999;33(1):60–5. 13. Sjaastad I, Sejersted OM, Ilebekk A, Bjørnerheim R, Bjornerheim R. Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl …. 2000;89(4):1445–54. 14. Martinez PF, Okoshi K, Zornoff LAM, Oliveira SA, Campos DHS, Lima ARR, et al. Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol. 2011;111(2):543–51. 15. Nunes RB, Tonetto M, Machado N, Chazan M, Heck TG, Veiga ABG, et al. Physical exercise improves plasmatic levels of IL-10, left ventricular end- diastolic pressure, and muscle lipid peroxidation in chronic heart failure rats. J Appl Physiol. 2008;104(6):1641–7. 16. Jaenisch RB, Hentschke VS, Quagliotto E, Cavinato PR, Schmeing LA, Xavier LL, et al. Respiratory muscle training improves hemodynamics, autonomic function, baroreceptor sensitivity, and respiratory mechanics in rats with heart failure. J Appl Physiol. 2011;111(6):1664–70. 17. Lindpaintner K, Lu W, Neidermajer N, Schieffer B, Just H, Ganten D, et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 1993;25(2):133–43. 18. Soci UPR, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, Rosa KT, et al. MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics. 2011;43(11):665–73. 19. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184–91. 20. Ko ń ca K, Lankoff A, Banasik A, Lisowska H, Kuszewski T, Gó ź d ź S, et al. A cross-platform public domain PC image-analysis program for the comet assay. Mutat Res - Genet Toxicol Environ Mutagen. 2003;534(1):15–20. 21. Ahmed MAE, El Morsy EM, Ahmed AAE. Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats. Life Sci. 2014;110(2):61–9. 22. Alves JP, Nunes RB, Stefani GP, Dal Lago P. Resistance training improves hemodynamic function, collagen deposition and inflammatory profiles: Experimental model of heart failure. PLoS One. 2014;9(10):e110317. 23. Hentschke VS, Jaenisch RB, Schmeing LA, Cavinato PR, Xavier LL, Dal Lago P. Low-level laser therapy improves the inflammatory profile of rats with heart failure. Lasers Med Sci. 2013;28(3):1007–16. 24. Bing OHL, Brooks WW, Conrad CH, Sen S, Perreault CL, Morgan JP. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ Res. 1991;68(5):1390–400. 25. Minicucci MF, Azevedo PS, Martinez PF, Lima ARR, Bonomo C, Guizoni DM, et al. Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats. Int J Cardiol. 2011;151(2):242-3. 26. Wu LL, ChiouCC, Chang PY,Wu JT. Urinary 8-OHdG: Amarker of oxidative stress toDNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1):1–9. 27. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress andDNA damage in human carcinogenesis. Mutat Res - FundamMol Mech Mutagen. 2011;711(1):193–201. 28. Kroese LJ, Scheffer PG. 8-hydroxy-2’-deoxyguanosine and cardiovascular disease: a systematic review. Curr Atheroscler Rep. 2014 Nov;16(11):452. 29. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal. 2006;8(9–10):1737–44. 30. Jaenisch RB, Stefani GP, Durante C, Chechi C, Hentschke VS, Rossato DD, et al. Respiratory muscle training decreases diaphragmDNA damage in rats with heart failure. Can J Physiol Pharmacol. 2017 Aug 8;96(3):221–6. 31. DrexlerH,RiedeU,MünzelT,KönigH,FunkeE, JustH.Alterationsofskeletal muscle in chronic heart failure. Circulation. 1992;85:1751–9. 32. Ventura-Clapier R, De Sousa E, Veksler V. Metabolic Myopathy in Heart Failure. News Physiol Sci. 2002;17(5):191–6. 33. JessupM,BrozenaS.Heartfailure.NEnglJMed.2003May;348(20):2007–18. 34. Chiong M, Wang Z V., Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, et al. Cardiomyocyte death: Mechanisms and translational implications. Cell Death Dis. 2011;2(12):e244. 35. Whelan RS, Kaplinskiy V, Kitsis RN. Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance. Annu Rev Physiol. 2010;72:19–44. 36. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heide F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science (80- ). 2009;324(5923):98–102. 37. Callahan DM, TothMJ. Skeletal muscle proteinmetabolism in human heart failure. Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):66–71. 38. Bechara LRG, Moreira JBN, Jannig PR, Voltarelli VA, Dourado PM, Vasconcelos AR, et al. NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats. Int J Cardiol. 2014;175(3):499–507. 39. Nickel A, Löffler J, Maack C. Myocardial energetics in heart failure. Basic Res Cardiol. 2013;108(4):358. Referências 241